Last reviewed · How we verify

NCT03519763

Intrauterine Microbiota During IVF in Patients Affected With Isthmocele.

Completed Last updated 25 February 2020
What this trial tests

trial testing ultrasound in Endometrial Diseases in 3 participants. Completed in 24 February 2020.

Timeline
13 June 2018
Primary endpoint
30 November 2019
24 February 2020

Quick facts

Lead sponsorART Fertility Clinics LLC
StatusCompleted
Study typeOBSERVATIONAL
Enrollment3
Start date13 June 2018
Primary completion30 November 2019
Estimated completion24 February 2020
Sites1 location across United Arab Emirates

Drugs / interventions tested

Conditions studied

Sponsor

ART Fertility Clinics LLC

Who can join

Adults 18 to 45, female only, with Endometrial Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the endometrial and isthmic microbiota in patients with isthmocele after C-Section, and if this microbiota is similar or not with better reproductive outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ultrasound

Trials testing the same drug.

Other recruiting trials for Endometrial Diseases

Currently open trials in the same condition.

Other ART Fertility Clinics LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03519763.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing